|
Pediatrics
Effect of Rimonabant, a Canabinoid Receptor 1 Antagonist on Weight Gain and Body Composition in Adults with Prader Willi Syndrome
Investigator: Roja Motaghedi, M.D.
Phone Number: (212) 746-3462
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics
and...
Investigator: Bussel, James B
Phone Number: x6-3474
A Phase I, Open-Label, Multiple-Center, Single-Dose-Escalating, Safety, Tolerability, Immunogenicity, Pharmacokinetic and
Pharmacodynamic Study...
Investigator: Bussel, James B
Phone Number: x6-3474
A Phase II, Single Center, Open Label, Efficacy and Safety, Ascending Dose, Pilot Study of R935788 for the Treatment of Adult
Refractory Immune
Investigator: Bussel, James B
Phone Number: x6-3474
A Randomized Trial Comparing Higher Doses of Rituximab (Rituxan) w/ Standard Doses of Rituxan in Combination with CVP in Subjects
with Chronic ITP
Investigator: Bussel, James B
Phone Number: x6-3474
A Randomized, Double-Blind, Placebo-Controlled Phase III Study, to Evaluate the Efficacy, Safety and Tolerability of Eltrombopag
Olamine...
Investigator: Bussel, James B
Phone Number: x6-3474
A Randomized, Placebo Controlled Study Evaluating the Efficacy & Safety of AMG 531 Treatment of Thrombocytopenic Subjects
with...
Investigator: Bussel, James B
Phone Number: x6-3474
An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thromboctopenic Subjects with Immune
(Idiopathic)...
Investigator: Bussel, James B
Phone Number: x6-3474
EXTEND (Eltrombopag eXTENded Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in adults, with idiopathic
thrombocytopenic ...
Investigator: Bussel, James B
Phone Number: x6-3474
Research Study Evaluating the Sysmex Automated Hematology Analyzer
Investigator: Bussel, James B
Phone Number: x6-3474
The Effects of Long-Term Dosing with AMG 531on Bone Marrow Morphology in Thrombocytopenic Subjects with Immune (Idiopathic)
Thrombocytopenic...
Investigator: Bussel, James B
Phone Number: x6-3474
A multicenter study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital hemophilia
A who develop...
Investigator: DiMichele, Donna M
Phone Number: x6-3418
Epidemiology and Treatment of Circulating Anticoagulants in Patients with Hemophilia and vWd -- Hemophilia and Thrombosis
Research Society Registry
Investigator: DiMichele, Donna M
Phone Number: x6-3418
Females with Severe or Moderate Hemophilia A or B: A Multi-center Study
Investigator: DiMichele, Donna M
Phone Number: x6-3418
Hemophilia Inhibitor Genetics Study (HIGS)
Investigator: DiMichele, Donna M
Phone Number: x6-3418
Immune Tolerance Induction in Patients with Hemophilia A and High Titer Inhibitor Utilizing Regimens Containing Plasma Derived
Factor VIII and von...
Investigator: DiMichele, Donna M
Phone Number: x6-3418
RAHF-RFM: Previously Untreated Patients with Hemophilia A (PUPS)
Investigator: DiMichele, Donna M
Phone Number: x6-3418
Second Multicenter Hemophilia Cohort Study
Investigator: DiMichele, Donna M
Phone Number: x6-3418
A 48 Week, Phase II, Non-Comparative, Open-label, Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokenetics
and Antiviral
Investigator: Freedman, Abigail
Phone Number: 746-4149
A Prospective, Open-label, Non-randomized, Naturalistic, Long-term Safety Surveillance, Observational Study of Ciprofloxacin...
Investigator: Freedman, Abigail
Phone Number: 746-4149
A Randomized, Comparative, Open Label Phase III Trial of Efficacy and Safety of Long-Term Treatment with ICL670 in Comparison
with Deferoxamine...
Investigator: Giardina, Patricia Jane
Phone Number: x6-3446
Phase II Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effect of Deferoxamine with or without...Assessed
by MRI in Adults with ...
Investigator: Giardina, Patricia Jane
Phone Number: x6-3446
Intervention Epidemiologic Research Studies of HIV/AIDS
Investigator: Ipp, Lisa S
Phone Number: x6-3372
Protocol #N01009 "A Double-Blind, Randomized, Multicenter, Placebo-Controlled, In-Patient, Maximum 34 Day Study of Levetiracetam
Oral Solution...
Investigator: Kosofsky, Barry
Phone Number: x6-3321
Transfusion Therapy Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Repair (FOCUS)
Investigator: Lyden, John P
Phone Number: 212-606-1126
The Safety & Efficacy of IV anti-D for the Treatment of Thrombocytopenia in Patients...
Investigator: Marks, Kristen
Phone Number: 746-4149
Novel Therapies in Hemostasis and Transfusion Medicine
Investigator: Skerrett, Donna
Phone Number: 746-4149
Genentech National Cooperative Growth Study (NCGS) Post Marketing Surveillance Program for Nutropin Depot, Nutropin AQ, Nutropin
and Protropin
Investigator: Vogiatzi, Maria G
Phone Number: x6-3462
Genetics and Neuroendocrinology of Short Stature International Study
Investigator: Vogiatzi, Maria G
Phone Number: x6-3462
|
